Status | Study |
RECRUITING |
Study Name: Monitoring Biomarker for Detecting Change in Physical Activity and Limb Function in Inclusion Body Myositis Over Time Condition: Inclusion Body Myositis Date: 2023-11-22 Interventions: The PAMSysTM sensor consists of a 3-axis accelerometer, battery, and built-in memory for recording long-term data.Accelerometer data is recorded |
RECRUITING |
Study Name: A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis Condition: Inclusion Body Myositis Date: 2023-02-01 Interventions: Given by subcutaneous injection |
RECRUITING |
Study Name: Phase III Trial of Sirolimus in IBM Condition: Inclusion Body Myositis Date: 2021-02-15 Interventions: Sirolimus is a currently licensed drug primarily used for immunosuppression post-kidney transplantation to prevent organ rejection.Sirolimus was |
Recruiting |
Study Name: Optimizing Treatment on Idiopathic Inflammatory Myopathies Condition: Idiopathic Inflammatory Myopathies Date: 2017-03-09 Interventions: Drug: Intravenous Infusion Intravenous infusion of follow medicine at disease onset: methyprednisolone a |
Recruiting |
Study Name: Physical Training in Patients With Idiopathic Inflammatory Myopathies Condition: Idiopathic Inflammatory Myopathies Physical Activity Date: 2017-03-09 Interventions: Other: Physical exercises Physical exercises |
Not yet recruiting |
Study Name: Study of Arimoclomol in Inclusion Body Myositis (IBM) Condition: Inclusion Body Myositis Date: 2016-04-25 Interventions: Drug: Arimoclomol 2 200mg pill |
Not yet recruiting |
Study Name: Pharmacoepidemiologic General Research Extension: PGRx-sIBM Study Condition: Sporadic Inclusion Body Myositis Date: 2016-04-06 |
Active, not recruiting |
Study Name: An Extension Study of the Efficacy, Safety and Tolerability of BYM338 (Bimagrumab) in Patients With Sporadic Inclusion Body Myositis Who Previously Participated in the Core Study CBYM338B2203 Condition: Sporadic Inclusion Body Myositis Date: 2015-07-09 Interventions: Drug: Bimagrumab Other Name: B |
Active, not recruiting |
Study Name: Rapamycine vs Placebo for the Treatment of Inclusion Body Myositis Condition: Inclusion Body Myositis (IBM) Date: 2015-05-13 Interventions: Drug: Rapamycin Experimental: |
Completed |
Study Name: Blood-flow Restricted Exercise in Inclusion Body Myositis Condition: Sporadic Inclusion Body Myositis Date: 2014-12-10 Interventions: Other: Blood-flow restricted training |